WCT:NASDAQWellchange Holdings Company Limited Analysis
Data as of 2026-07-28 - not real-time
$0.90
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Technical outlook: The stock is trading at $0.90, barely above the identified support of $0.785 and well below the 20‑day SMA of 1.04, indicating a bearish bias. The 50‑day SMA (1.36) sits far above price, and the 200‑day SMA (6.22) is an order of magnitude higher, underscoring a long‑term downtrend. Momentum is neutral‑to‑weak with an RSI of 41, while the MACD line has just crossed above its signal, producing a tiny bullish histogram but not enough to offset the prevailing bearish trend. Volume is decreasing, and the 30‑day volatility exceeds 160%, suggesting erratic price swings.
Fundamental outlook: Revenues have collapsed by roughly 88% year‑over‑year, and the company is operating at a -20% operating margin with zero net profit. Cash flow is deeply negative (operating cash flow and free cash flow both in the -$6‑8 million range) and the balance sheet shows a high debt‑to‑equity of 4.69, despite a modest cash balance. Return metrics (ROE, ROA) are profoundly negative, and the stock trades at a price‑to‑book of 0.25, implying extreme undervaluation relative to book value but no earnings to support that price. No dividend is paid, and the market cap is only $4 million, making liquidity a concern. Overall, the combination of a steep price decline, deteriorating fundamentals, and heightened volatility points to a high‑risk, speculative position.
Fundamental outlook: Revenues have collapsed by roughly 88% year‑over‑year, and the company is operating at a -20% operating margin with zero net profit. Cash flow is deeply negative (operating cash flow and free cash flow both in the -$6‑8 million range) and the balance sheet shows a high debt‑to‑equity of 4.69, despite a modest cash balance. Return metrics (ROE, ROA) are profoundly negative, and the stock trades at a price‑to‑book of 0.25, implying extreme undervaluation relative to book value but no earnings to support that price. No dividend is paid, and the market cap is only $4 million, making liquidity a concern. Overall, the combination of a steep price decline, deteriorating fundamentals, and heightened volatility points to a high‑risk, speculative position.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Price hovering just above technical support
- Decreasing volume and extreme short‑term volatility
- Negative operating cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential for price stabilization near support
- Undervalued price‑to‑book ratio
- Uncertain turnaround prospects
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained revenue collapse and negative margins
- High debt burden relative to equity
- Lack of dividend and limited market liquidity
Key Metrics & Analysis
Financial Health
Revenue Growth-87.90%
ROE-91.17%
ROA-38.92%
Debt/Equity4.69
P/B Ratio0.2
Op. Cash Flow$-6317821
Free Cash Flow$-8152262
Industry P/E32.1
Technical Analysis
TrendBearish
RSI41.2
Support$0.79
Resistance$1.39
MA 20$1.04
MA 50$1.36
MA 200$6.22
MACDBullish
VolumeDecreasing
Fear & Greed Index89.07
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.04
Volatility162.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.